The purpose of the randomized control trial is to estimate the effect of an oncology clinical nurse specialist-led early intervention multidisciplinary approach to palliative and survivorship care within two previously identified and validated patient groups having metastatic solid tumor malignancy on patient-reported symptom burden, patient-reported overall quality of life (QOL), distress, and overall survival. The primary hypothesis is that the effect of an oncology clinical nurse specialist- led early intervention multidisciplinary palliative and survivorship care model will be significantly higher, as compared to the standard of care approach to palliative and survivorship care, on the primary endpoint of patient-reported symptom burden for patients with metastatic solid tumor malignancy within favorable and very favorable risk groups. Symptom burden includes pain, tiredness, drowsiness, nausea, lack of appetite, depression, anxiety, shortness of breath, and wellbeing.
adult patients (21 yrs and over)
metastatic solid tumor malignancy with very favorable and favorable prognostic curves
under the care of GSUH oncology and radiation oncology clinicians
patients with metastatic solid tumor malignancy who are < 21 yrs of age
adult patients with metastatic solid tumor malignancy who are in standard risk and unfavorable prognostic curves
patients not under the care of GSUH oncology and radiation oncology clinicians
Parallel
Palliative and Survivorship Care Model
BehavioralThe standard of care comparator arm is usual clinical care using NCCN guidelines and evidence-based practice for palliative and survivorship care.
participant reported symptom burden
The Edmonton Symptom Assessment System- Revised (ESAS-r) will be used to measure patient reported symptom burden
participant reported quality of life
Updated NCCN Distress Thermometer Problem List for Patients will be used to measure participant reported quality of life
participant reported distress
Updated NCCN Distress Thermometer will be used to measure participant reported distress
participant overall survival
Measured as survival at 60 months
Click on the lead sponsor to view all of their trials.
